Title: Assessment of two doses of infliximab in patients with low/intermediate risk IPSS myelodysplastic syndrome (MDS): An EORTC leukemia group (LG) randomized phase II trial (06023)
Authors: Baila, Liliana
Suciu, Stefan
Muus, Petra
Amadori, Sergio
Delforge, Michel
Ossenkoppele, Gert
Selleslag, Dominik L. D
Thyss, Antoine
Demuynk, Hilde
Gadisseur, Alain
Vermeulen, Pieter
De Boer, Carla
Zwierzina, Heinz
De Witte, T. M
Issue Date: Nov-2007
Publisher: Amer soc hematology
Host Document: Blood vol:110 issue:11 pages:436A-436A
Conference: ASH edition:2007 location:Atlanta date:8-11 december 2007
ISSN: 0006-4971
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Hematology Section (-)

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.